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Abstract
The objective of the present study was to develop a quantitative method to evaluate laser-induced choroidal neovascularization 
(CNV) in a rat model using Heidelberg Retina Angiograph 2 (HRA2) imaging. The expression of two heparan sulfate proteo-
glycans (HSPG) related to inflammation and angiogenesis was also investigated. CNV lesions were induced with argon laser 
in 21 heterozygous Zucker rats and after three weeks a fluorescein angiogram and autofluorescence exams were performed 
using HRA2. The area and greatest linear dimension were measured by two observers not aware of the protocol. Bland-Altman 
plots showed agreement between the observers, suggesting that the technique was reproducible. After fluorescein angiogram, 
HSPG (perlecan and syndecan-4) were analyzed by real-time RT-PCR and immunohistochemistry. There was a significant 
increase in the expression of perlecan and syndecan-4 (P < 0.0001) in retinas bearing CNV lesions compared to control reti-
nas. The expression of these two HSPG increased with increasing CNV area. Immunohistochemistry demonstrated that the 
rat retina damaged with laser shots presented increased expression of perlecan and syndecan-4. Moreover, we observed that 
the overexpression occurred in the outer layer of the retina, which is related to choroidal damage. It was possible to develop 
a standardized quantitative method to evaluate CNV in a rat model using HRA2. In addition, we presented data indicating that 
the expression of HSPG parallels the area of CNV lesion. The understanding of these events offers opportunities for studies of 
new therapeutic interventions targeting these HSPG.
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Introduction
Age-related macular degeneration associated with 
choroidal neovascularization (CNV) is a major cause of 
severe visual loss in western countries (1). The newly 
formed vessels, originating from the choroid, grow into the 
subretinal space, where they are recognized clinically by 
fluorescence leakage during a fluorescein angiogram (FA) 
(2). CNV may also be a common finding in many other eye 
diseases, such as pathological myopia, angioid streaks and 
presumed ocular histoplasmosis syndrome.
In 1979, Ryan (3) developed the first animal model for 
CNV using Rhesus monkeys and argon laser photocoagula-
tion to damage Bruch’s membrane. Since then, other models 
have been developed in mice, rats and pigs using argon 
and diode lasers, mechanical stress, enzymatic digestion 
of Bruch’s membrane, transchoroidal infusion of fibroblast 
growth factor-2 (FGF-2) or vascular endothelial growth 
factor (VEGF) (4-7). A current reproducible animal model 
for CNV studies is the choroidal damage induced by argon 
or diode laser in mice and rats (8-10).
Quantitative assessment of retinal and choroidal morphol-
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ogy is a critical step in the study of the physiopathology of neo-
vascular disease, and is used to monitor disease progression 
and to evaluate the effects of drugs on CNV inhibition.
The Heidelberg Retina Angiograph 2 (HRA2) is a digital 
confocal scanning laser ophthalmoscope (cSLO) used for 
fundus imaging. It is based on the property of scanning 
the fundus with a laser beam from a point source, while 
the reflected light is detected by a photomultiplier detector. 
Incident and reflected lights follow a coaxial path (11). 
Several studies have described the use of fundus im-
aging in rodent models for a variety of diseases (11-16). 
However, the methods published thus far do not allow 
precise quantitative measurements of CNV. 
Angiogenesis is an intricate process that involves 
many steps including a myriad of angiogenic agents as 
growth factors, limited proteolysis mediated by specific 
metalloproteinases and the interaction of components of 
the extracellular matrix (ECM) with their receptors (17-19). 
Heparan sulfate proteoglycans (HSPG) have been shown 
to be involved in the modulation of neovascularization, and 
are ubiquitously found on the cell surface and in the ECM 
of all animal species (20,21). The heparan sulfate chains, 
due to their vast structural diversity, are able to bind and 
interact with a wide variety of proteins, such as growth 
factors, chemokines, morphogens, ECM components, 
enzymes, and others (22,23). Among the cell surface 
HSPG, syndecan-4 is always present in endothelial cells. 
The heparan sulfate chains of syndecan-4 are considered 
to play various roles by binding and modulating growth 
factors such as FGF-2, VEGF, tumor growth factor-β 
(TGF-β), anticoagulation factors, such as tissue factor 
pathway inhibitors, and cell adhesion molecules (24,25). 
These interactions trigger signaling pathways either directly 
by the phosphorylation of cytoplasmic proteins or via the 
cytoskeleton by the use of the cytoplasmic domain of the 
core protein (26). Furthermore, syndecan-4 also contributes 
to endothelial tubulogenesis (27). 
Perlecan is a basement membrane HSPG, which can 
bind several growth factors such as FGF, VEGF, and PDGF, 
among others (28). Perlecan not only has structural roles 
in the molecular assembly and maintenance of basement 
membranes, but can also play an instructive role by provid-
ing information to integrins and to other surface receptors 
by acting as co-receptors and growth factor scavengers. 
All of these biological activities undoubtedly influence the 
proliferation, migration and morphogenesis of endothelial 
cells (29,30). HSPG play an important role in inflammation 
since there is evidence that these molecules interact with 
L-selectin and chemokines (21,31).
The present study was designed to develop a quantita-
tive method to evaluate laser-induced CNV in a rat model 
using HRA2. Since HSPG are involved in inflammation and 
angiogenesis, the expression of perlecan and syndecan-4 
in retina was also investigated by real-time RT-PCR and 
immunohistochemistry. 
Material and Methods
Animals
All experiments were performed in accordance with 
the Association for Research in Vision and Ophthalmology 
Statement for Use of Animals in Ophthalmic and Vision 
Research, and in accordance with a protocol reviewed and 
approved by the Animal Care Committee of the Federal 
University of São Paulo (#1388/06). The study was car-
ried out on 21 female heterozygous pigmented Zucker rats 
weighing 180 to 220 g.
Induction of choroidal neovascularization
Animals were anesthetized with an intramuscular 
injection of a mixture of 56 mg/kg ketamine and 6 mg/kg 
xylazine. The pupil was then dilated by topical application of 
a combination of 1% tropicamide and 2.5% phenylephrine 
hydrochloride (Allergan, Brazil). Photocoagulation was 
performed using an argon laser (532 µm) connected to 
a slit lamp delivery system (SL 115 Slit Lamp, Carl Zeiss 
Meditec, Germany). A hand-held coverslip was used as a 
contact lens by direct contact with the cornea of the animals 
using 1% methyl cellulose (Ophthalmos, Brazil). Four lesions 
located at the 3, 6, 9, and 12 o’clock meridians, centered 
on the optic nerve head and located approximately 2 disc 
diameters from the head of the optic nerve, were created 
using a power of 300 mW, spot size of 100 µm and duration 
of 100 ms. The objective was to create a rupture in Bruch’s 
membrane, confirmed by bubble formation, to allow the 
invasion of the subretinal space by choroidal blood vessels, 
resulting in a neovascular membrane. This procedure was 
performed in the right eye of 21 animals, and the left eye 
was used as control. 
Fluorescein angiogram
Three weeks after CNV induction, animals were anes-
thetized and pupils dilated as described above. FA was 
performed using an HRA2 instrument (Heidelberg Engi-
neering, Germany) (11). The highest definition image was 
768 x 768 pixels. CNV lesion was measured using a 55° 
lens with the same focus in all cases. Autofluorescence is a 
property of fundus image without the use of any fluorescent 
substance when it is excited with a 488-nm wavelength 
laser. The images were obtained with HRA2 (32) before 
fluorescein injection. Rats were manually held in front of 
HRA2 device, in an upright position and FA was performed. 
Fluorescein injections were administered intraperitoneally 
(0.2 mL 2% fluorescein; Ophthalmos), and the timer was 
started as soon as the fluorescein bolus was injected. All 
early images were captured immediately after fluorescein 
injection and all late phase images 12 min after the injec-
tions. During the exams the corneas were keep moist with 
2% methylcellulose (Ophthalmos). Twenty-one days after 
laser induction of CNV, two observers with experience in FA 
evaluation and not involved in the experiments assessed 
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the FA. The image of the fluorescein leakage area in the 
late phase was reported in square millimeters (mm2) using 
HRA2 software. The image of the greatest linear diameter 
was also measured in millimeters (mm). 
Retinal RNA extraction and gene expression analysis 
After 3 weeks, eyes from three animals (6 eyes, 3 con-
trol eyes and 3 with laser-induced CNV: rat 1, rat 2 and rat 
3) were enucleated and the retina was removed for RNA 
extraction. Detection of mRNAs encoding syndecan-4, 
perlecan and β-actin (as endogenous control) was ana-
lyzed by quantitative RT-PCR. Total retinal tissue RNA was 
isolated using Trizol reagent (Gibco BRL, USA), followed 
by the synthesis of cDNA by reverse transcription using 
the IMPRON II kit (Promega, USA). The sets of primers 
used were as follows: perlecan: sense 5’-CTGCCACCTG 
ACAGTCGC-3’ and antisense 5’-GCTCTGGCACCTGC 
AG-3’ (gene data bank accession number NM 005529.5); 
syndecan-4: sense 5’-GGGCAGCAACATCTTTGAGAG-3’ 
and antisense 5’-TCCTTCTTCTTCATACGGTAC-3’ (gene 
data bank accession number NM 002999.2); β-actin: 
sense 5’-CATCCTGCGTCTGGACCTGG-3’ and antisense: 
5’-GGCAGCTCATAGCTCTTC-3’ (gene data bank acces-
sion number NM 001101.3).
Is important to point out that are similarities between 
Rattus novergicus and Homo sapiens in these HSPG genes. 
Real-time PCR was performed using a 7500 real-time PCR 
System (Applied Biosystems, USA) and the reactions were 
performed using SYBR Green PCR Master Mix reagents 
(Applied Biosystems). Temperatures were set at 55°C for 
annealing, 72°C for extension and 94°C for denaturation 
for 45 cycles for all genes analyzed. The experiments 
were performed in hexaplicate and data are reported as 
means ± SEM.
Quantification and localization of HSPGs by 
immunohistochemistry
Formaldehyde-fixed paraffin-embedded eyes submitted 
or not to laser shots were investigated. After clearing with 
xylene, the slides were dehydrated in alcoholic solutions, 
treated with 3% H2O2 for 35 min to inhibit endogenous 
peroxidase activity, and blocked with 1% bovine serum 
albumin for 1 h. The slides were then incubated overnight 
with primary antibodies: a mouse monoclonal anti-syndecan 
4 (4E12A8 clone) raised against the 29N-terminal portion of 
the syndecan-4 protein and a polyclonal anti-perlecan (Santa 
Cruz, USA). After washing in PBS, sections were incubated 
with the universal LSAB kit (Dako, Denmark), washed in PBS 
and incubated with a liquid diaminobenzidine substrate (10 
s; Dako). The slides were finally counterstained with he-
matoxylin and analyzed by light microscopy (Nikon Eclipse 
E600, objective 20 or 40X).
Statistical analysis 
To assess interobserver reproducibility, leakage area 
and greatest linear dimension were compared for the images 
acquired by observer 1 and observer 2 using Bland-Altman 
plots (33). The reproducibility of these features was quanti-
fied using the bias (mean difference) and analyzed by the 
concordance coefficient (34) with a 95% confidence interval. 
The minimum required sample is 13 animals assuming a 
sampling error of 10 mm for greatest linear diameter and a 
95% confidence (34). Data are reported as means ± SEM for 
real-time PCR analysis. Statistical analyses were performed 
by one-way ANOVA with Bonferroni’s post-test using the 
Graph Pad Prism 5.0 software for Windows. A 95% confi-
dence interval and a 5% level of significance were adopted. 
P values ≤0.05 were considered to be significant. 
Results
Fluorescein angiogram analysis
Three weeks after laser induction, 73 of 84 lesions 
(86.9%) presented clinically significant leakage by FA. 
Two eyes presented cataract formation, but FA could still 
be performed. Satisfactory fundus imaging was obtained in 
all exams. The exams were performed easily without any 
complementary lens.
The measurement of the greatest linear diameter as 
well as the leakage area reported by different examiners 
was statistically similar, indicating interexaminer reproduc-
ibility. Both observers easily measured the entire leakage 
area and greatest linear diameter using the HRA software. 
The mean area reported by examiner 1 was 1909 ± 324 
mm2 and the mean area reported by examiner 2 was 2115 
± 333 mm2. Examiner 1 reported a mean greatest linear 
diameter of 58.16 ± 4.6 mm and examiner 2 reported a value 
of 55.8 ± 5.0 mm based on same images. A Bland-Altman 
plot showed good interexaminer agreement for measuring 
greatest linear diameter, suggesting that this technique is 
reproducible. The mean difference in the measurement of 
greatest linear diameter between the two examiners was 
0.4 with limits of agreement of 95% (-29.4; +30.1) and the 
values were equally distributed around negative and positive 
differences (Figure 1). Good concordance coefficients for 
both greatest linear diameter and area were found (0.624 
and 0.606, respectively). The concordance interval was 
0.231-0.844 with P = 0.002 for greatest linear diameter and 
0.204-0.836 with P = 0.003 for area.
The lesion shape observed in the FA was similar in 
all cases and the intensity of leakage was sufficient to 
determine the area in the late phase. Figure 2A shows the 
control eye and Figure 2B,C shows FA after 21 days of 
laser-induced CNV, illustrating the circulatory filling of the 
vessels. The autofluorescence exam using the 488-nm 
laser did not present any hyperautofluorescent points in 
the control eye (Figure 2D). On the other hand, in animals 
submitted to laser shots, hyperautofluorescent points were 
observed surrounding the CNV lesions (Figure 2E,F). Auto-
fluorescence was present in 50% of CNV lesions and was 
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not related to lesion size or serous retinal detachment.
Expression of heparan sulfate proteoglycans in the 
retina
The expression of syndecan-4, a typical endothelial cell 
surface proteoglycan, and perlecan, a typical endothelial 
cell ECM, was analyzed by real-time RT-PCR in three 
rat retinas (rat 1, rat 2 and rat 3). There was a significant 
increase (P < 0.0001) in the expression of both perlecan 
and syndecan-4 in retinas bearing CNV lesions compared 
to control retinas (Figure 3). The expression of these two 
HSPG increased with increasing CNV lesion area. The 
sum of the areas of 4 CNV lesions was rat 1 = 7,583, rat 2 
= 9,184, and rat 3 = 28,038 mm2.
Immunohistochemical analysis of HSPG in the retina 
Syndecan-4 and perlecan expression in rat retina with 
and without laser treatment was also investigated by immu-
nohistochemistry. Retinas submitted to laser shots showed 
increased expression of both syndecan-4 (Figure 4) and 
perlecan (Figure 5) compared to control retinas. An increase 
in the expression of syndecan-4 located on the cell surface 
Figure 1. Bland-Altman plot of greatest linear diameter measure-
ment by two examiners (Ex 1, Ex 2) [mean difference, 0.4; limits 
of agreement of 95% (-29.4; +30.1)].
Figure 2. Fluorescein angiogram and autofluorescence exam 
with HRA2 after three weeks of laser-induced choroidal neovas-
cularization (CNV). Panels A, B and C, Fluorescein angiogram 
in the same eye: control eye (A); initial phase using a 55° lens 
with zoom captured immediately after fluorescein injection (B); 
late phase acquired with a 55° lens captured 12 min after the 
fluorescein injections (C). Panels D, E and F, Autofluorescence 
exam acquired with a 55° lens: control eye (D); autofluorescence 
exam of two different eyes submitted to CNV (E,F).
Figure 3. Expression of syndecan 4 and perlecan in retinas 
submitted to laser-induced experimental choroidal neovascu-
larization (CNV). Expression was measured by quantitative RT-
PCR. The histograms show the relative expression of syndecan 
4 (Syn 4) or perlecan with respect to β-actin. Control = retinas 
without laser treatment; rat 1, 2, and 3 = experimental group sub-
mitted to CNV. *P < 0.0001 compared to other groups (ANOVA 
with Bonferroni’s post-test). 
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of the outer nuclear layer and photoreceptor segment lay-
ers can be seen after the laser shots. Similar results were 
obtained for perlecan, which was overexpressed in the 
ECM of the outer nuclear layer and photoreceptor segment 
layers after the laser shots. 
Figure 4. Immunohistochemical analysis of syndecan 4 in retinas after laser shots. The upper panels show a control 
retina. A, 20X magnification; B, C, 40X magnification. The lower panels show a retina submitted to laser shots, the 
immunohistochemical staining is showed in brown. D, 20X magnification; E, F, 40X magnification. The arrowhead 
indicates the brown staining of syndecan-4 in the outer nuclear layer and the open arrow indicates the brown staining 
of syndecan-4 in the photoreceptor segment layer.
Figure 5. Immunohistochemical analysis of perlecan in retinas after laser shots. The upper panels show a control 
retina. A, 20X magnification; B, C, 40X magnification. The lower panels show a retina submitted to laser shots. D, 
20X magnification; E, F, 40X magnification. The arrowhead indicates the brown staining of perlecan in the outer 
nuclear layer and the open arrow indicates the brown staining of perlecan in the photoreceptor segment layer.
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Discussion
The objective of this study was to assess the capability 
of cSLO to visualize and measure CNV. cSLO appears to be 
a useful technique for experimental studies of vitreoretinal 
diseases, especially vascular disease models, and can also 
be used as a technique for in vivo cellular imaging of the 
retina (11,35). Other current applications of cSLO include 
the study of neovascularization. In the present investiga-
tion, using cSLO we were able to develop a quantitative 
procedure to study neovascularization in an experimental 
CNV model. The entire CNV lesion was clearly and easily 
identified, corresponding to the leakage area. The mea-
surements could be easily performed using software, and 
reproducibility was demonstrated by agreement of data 
obtained by two observers who were not involved in the 
experiments. In contrast to previous reports (9), the FA 
and autofluorescence exams were performed without any 
additional lenses. According to Paques et al. (11), FA has 
the disadvantage of a limited field of a single image, with 
the need to obtain a composite image. In the experiments 
described here using the 55-degrees HRA2 lens we were 
able to evaluate the 4 CNV lesions in one image.
The in vivo autofluorescence of human retinal pigmented 
epithelium (RPE) provides a noninvasive technique that can 
be used in the investigation of inherited and age-related 
retinal diseases (36,37), permitting the assessment of the 
viability of the RPE/photoreceptor complex by the distribu-
tion of the levels of retinal fluorophores (38). The ocular fundi 
of individuals with degenerative macular diseases such as 
age-related macular degeneration show a dramatic, age-
dependent accumulation of retinal fluorophores (38). Our 
data show that autofluorescence is preserved in animals 
without laser-induced CNV, indicating normal function of 
the RPE/photoreceptor complex. In addition, the results 
obtained for the laser-induced CNV group were similar 
to those obtained for age-related macular degeneration, 
showing interesting images of hyperautofluorescent points 
close to the CNV lesion present in 50% of the lesions. We 
speculate that the hyperautofluorescent points are corre-
lated with the presence of lipofuscin fluorophores, which 
emit light in the broad range of 500-750 nm, indicating injury 
to the RPE/photoreceptor complex (39). 
Changes in HSPG expression were observed in retinas 
submitted to laser-induced CNV. The increased expres-
sion of HSPG in CNV lesions may be related to endothe-
lial dysfunction and increased capillary permeability. Our 
results showed that the major overexpressed HSPG was 
perlecan, that can serve as a scaffold for blood vessel for-
mation (40), modulating the activities of angiogenic growth 
factors. Immunohistochemistry confirmed this increase 
of perlecan. Moreover, we observed that overexpression 
occurred on the outer retina layers, which are related to 
choroidal damage. Similar results were also observed for 
the immunohistochemical staining of syndecan-4, which 
may be related to the inflammatory process evoked by this 
experimental model. A previous study showed an increase 
of heparan sulfate synthesis in retinas submitted to laser 
shots by using metabolic radiolabeling with [35S]-sulfate in 
the same experimental model (21). 
In summary, cSLO can be a useful and easy technique 
for the quantitative assessment of laser-induced CNV in a 
rat model. We presented data correlating the area of CNV 
lesion and the expression of heparan sulfate proteoglycans. 
The understanding of these events at the molecular level 
offers opportunities for new therapeutic interventions.
Acknowledgments
Research supported by FAPESP, CNPq, and CAPES.
References
 1. Cui JZ, Kimura H, Spee C, Thumann G, Hinton DR, Ryan 
SJ. Natural history of choroidal neovascularization induced 
by vascular endothelial growth factor in the primate. Graefes 
Arch Clin Exp Ophthalmol 2000; 238: 326-333.
 2. Teeters VW, Bird AC. The development of neovasculariza-
tion of senile disciform macular degeneration. Am J Ophthal-
mol 1973; 76: 1-18.
 3. Ryan SJ. The development of an experimental model of 
subretinal neovascularization in disciform macular degen-
eration. Trans Am Ophthalmol Soc 1979; 77: 707-745.
 4. Campochiaro PA. Retinal and choroidal neovascularization. 
J Cell Physiol 2000; 184: 301-310.
 5. Ryan SJ, Mittl RN, Maumenee AE. Enzymatic and mechani-
cally induced subretinal neovascularization. Albrecht Von 
Graefes Arch Klin Exp Ophthalmol 1980; 215: 21-27.
 6. Qiu G, Stewart JM, Sadda S, Freda R, Lee S, Guven D, et al. 
A new model of experimental subretinal neovascularization 
in the rabbit. Exp Eye Res 2006; 83: 141-152.
 7. Wang YS, Eichler W, Friedrichs U, Yafai Y, Hoffmann S, 
Yasukawa T, et al. Impact of endostatin on bFGF-induced 
proliferation, migration, and matrix metalloproteinase-2 
expression/secretion of bovine choroidal endothelial cells. 
Curr Eye Res 2005; 30: 479-489.
 8. Kvanta A, Shen WY, Sarman S, Seregard S, Steen B, 
Rakoczy E. Matrix metalloproteinase (MMP) expression in 
experimental choroidal neovascularization. Curr Eye Res 
2000; 21: 684-690.
 9. Shi X, Semkova I, Muther PS, Dell S, Kociok N, Joussen 
AM. Inhibition of TNF-alpha reduces laser-induced choroidal 
neovascularization. Exp Eye Res 2006; 83: 1325-1334.
10. Kohri T, Moriwaki M, Nakajima M, Tabuchi H, Shiraki K. 
Reduction of experimental laser-induced choroidal neovas-
cularization by orally administered BPHA, a selective met-
alloproteinase inhibitor. Graefes Arch Clin Exp Ophthalmol 
2003; 241: 943-952.
11. Paques M, Simonutti M, Roux MJ, Picaud S, Levavasseur E, 
Fluorescein angiogram of CNV in rats 633
www.bjournal.com.br Braz J Med Biol Res 43(7) 2010
Bellman C, et al. High resolution fundus imaging by confocal 
scanning laser ophthalmoscopy in the mouse. Vision Res 
2006; 46: 1336-1345.
12. Murata H, Aihara M, Chen YN, Ota T, Numaga J, Araie M. 
Imaging mouse retinal ganglion cells and their loss in vivo 
by a fundus camera in the normal and ischemia-reperfusion 
model. Invest Ophthalmol Vis Sci 2008; 49: 5546-5552.
13. Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV. A 
clinical grading system for retinal inflammation in the chronic 
model of experimental autoimmune uveoretinitis using digital 
fundus images. Exp Eye Res 2008; 87: 319-326.
14. Goldenberg-Cohen N, Dadon S, Avraham BC, Kramer M, 
Hasanreisoglu M, Eldar I, et al. Molecular and histological 
changes following central retinal artery occlusion in a mouse 
model. Exp Eye Res 2008; 87: 327-333.
15. Falkenstein IA, Cheng L, Wong-Staal F, Tammewar AM, Bar-
ron EC, Silva GA, et al. Toxicity and intraocular properties 
of a novel long-acting anti-proliferative and anti-angiogenic 
compound IMS2186. Curr Eye Res 2008; 33: 599-609.
16. Julien S, Kreppel F, Beck S, Heiduschka P, Brito V, 
Schnichels S, et al. A reproducible and quantifiable model 
of choroidal neovascularization induced by VEGF A165 after 
subretinal adenoviral gene transfer in the rabbit. Mol Vis 
2008; 14: 1358-1372.
17. Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: 
heavy hitters in the angiogenesis arena. J Clin Invest 2001; 
108: 349-355.
18. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura 
Y, et al. VEGF164-mediated inflammation is required for 
pathological, but not physiological, ischemia-induced retinal 
neovascularization. J Exp Med 2003; 198: 483-489.
19. Ng YS, Krilleke D, Shima DT. VEGF function in vascular 
pathogenesis. Exp Cell Res 2006; 312: 527-537.
20. Nader HB, Chavante SF, dos-Santos EA, Oliveira TW, de-
Paiva JF, Jeronimo SM, et al. Heparan sulfates and hepa-
rins: similar compounds performing the same functions in 
vertebrates and invertebrates? Braz J Med Biol Res 1999; 
32: 529-538.
21. Regatieri CV, Dreyfuss JL, Melo GB, Lavinsky D, Farah ME, 
Nader HB. Dual role of intravitreous infliximab in experimen-
tal choroidal neovascularization: effect on the expression 
of sulfated glycosaminoglycans. Invest Ophthalmol Vis Sci 
2009; 50: 5487-5494.
22. Sampaio L, Tersariol I, Lopes C, Bouças R, Nascimento F, 
Rocha H, et al. Heparins and heparans sulfates. Structure, 
distribution and protein interactions. In: Verli H (Editor), In-
sights into carbohydrate structure and biological function. 1st 
edn. Kerala: Transworld Research Network; 2006. p 12-24.
23. Dreyfuss JL, Regatieri CV, Jarrouge TR, Cavalheiro RP, 
Sampaio LO, Nader HB. Heparan sulfate proteoglycans: 
structure, protein interactions and cell signaling. An Acad 
Bras Cienc 2009; 81: 409-429.
24. Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans 
in wound healing, inflammation and vascular biology. Int J 
Biochem Cell Biol 2007; 39: 505-528.
25. Bass MD, Humphries MJ. Cytoplasmic interactions of syn-
decan-4 orchestrate adhesion receptor and growth factor 
receptor signalling. Biochem J 2002; 368: 1-15.
26. Beauvais DM, Rapraeger AC. Syndecans in tumor cell adhe-
sion and signaling. Reprod Biol Endocrinol 2004; 2: 3.
27. Nunes SS, Outeiro-Bernstein MA, Juliano L, Vardiero F, Na-
der HB, Woods A, et al. Syndecan-4 contributes to endothe-
lial tubulogenesis through interactions with two motifs inside 
the pro-angiogenic N-terminal domain of thrombospondin-1. 
J Cell Physiol 2008; 214: 828-837.
28. Gallagher JT. Multiprotein signalling complexes: regional 
assembly on heparan sulphate. Biochem Soc Trans 2006; 
34: 438-441.
29. Bix G, Iozzo RV. Novel interactions of perlecan: unraveling 
perlecan’s role in angiogenesis. Microsc Res Tech 2008; 71: 
339-348.
30. Knox SM, Whitelock JM. Perlecan: how does one molecule 
do so many things? Cell Mol Life Sci 2006; 63: 2435-2445.
31. Celie JW, Beelen RH, van den Born J. Heparan sulfate pro-
teoglycans in extravasation: assisting leukocyte guidance. 
Front Biosci 2009; 14: 4932-4949.
32. Dolar-Szczasny J, Mackiewicz J, Bindewald A, Holz FG, 
Zagorski Z. [Fundus autofluorescence examination using a 
confocal scanning laser ophthalmoscope HRA (Heidelberg 
Retina Angiograph)]. Klin Oczna 2005; 107: 544-547.
33. Bland JM, Altman DG. Statistical methods for assessing 
agreement between two methods of clinical measurement. 
Lancet 1986; 1: 307-310.
34. Altman DG. Practical statistics for medical research. Lon-
don: Chapman & Hall; 1991.
35. Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones 
HE, et al. Real-time imaging of single nerve cell apoptosis in 
retinal neurodegeneration. Proc Natl Acad Sci U S A 2004; 
101: 13352-13356.
36. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, 
Weiter JJ. In vivo fluorescence of the ocular fundus exhibits 
retinal pigment epithelium lipofuscin characteristics. Invest 
Ophthalmol Vis Sci 1995; 36: 718-729.
37. von Ruckmann A, Fitzke FW, Bird AC. Fundus autofluores-
cence in age-related macular disease imaged with a laser 
scanning ophthalmoscope. Invest Ophthalmol Vis Sci 1997; 
38: 478-486.
38. Vaclavik V, Vujosevic S, Dandekar SS, Bunce C, Peto T, 
Bird AC. Autofluorescence imaging in age-related macular 
degeneration complicated by choroidal neovascularization: 
a prospective study. Ophthalmology 2008; 115: 342-346.
39. Bui TV, Han Y, Radu RA, Travis GH, Mata NL. Characteriza-
tion of native retinal fluorophores involved in biosynthesis of 
A2E and lipofuscin-associated retinopathies. J Biol Chem 
2006; 281: 18112-18119.
40. Jiang X, Couchman JR. Perlecan and tumor angiogenesis. 
J Histochem Cytochem 2003; 51: 1393-1410.
